Background: COPD is a chronic disease which may have substantial effect on quality of life of patients. Aim: The aim of this study is to study the impact of COPD on activities of daily living and quality of life of patients and to correlate the impact with severity of disease in the set up of Indian conditions. Materials and methods: In this prospective study conducted at a tertiary level hospital, stable COPD patients without any other coexisting co-morbidity were enrolled. The severity of COPD was classifi ed as per GOLD 2006 guidelines. The quality of life and impact of COPD on activities of daily living was assessed using Seattle obstructive lung disease questionnaire translated in local language, 6 minutes walk test and visual analog scale for dyspnoea. Results: Seventy eight patients and 20 controls were enrolled for the study. The scores for physical functions, emotional functions, coping skills and treatment satisfaction obtained from questionnaire were decreased in COPD patients. The physical function and emotional function score, decreased signifi cantly (P < 0.05) when compared from mild through moderate, severe and very severe stages of COPD, these scores also correlated positively with percent predicted FEV 1 values in spirometry (r=0.855 and r = 0.735 respectively) There was a signifi cant fall in the six minute walk distance as the stage of disease progressed. The Visual analog scale score signifi cantly increased (P < 0.05) with the stage of COPD. Conclusion: Assessing quality of life and ability to perform activities of daily living is also important for assessing the disease severity.
INTRODUCTION
Health related quality of life (HRQoL) measures the impact of an individual's health on his or her ability to perform and enjoy the activities of daily life. [1] Chronic Obstructive Pulmonary Disease (COPD) has substantial impact on quality of life, impairing not only physical, but also psychological and social functions. Therefore, in addition to assessment of degree of airfl ow obstruction by spirometry, it is important to measure health related quality of life in these patients. Various tools and questionnaires have been developed to assess the HRQoL. One of such tools for chronic respiratory diseases is: Seattle obstructive lung disease Questionnaire (SOLDQ). [2] It is reliable, valid and measures physical and emotional function, coping skills and treatment satisfaction in patients with COPD. It is self administered, brief and can be scanned via computer. The aim of this study was to study the impact of COPD on activities of daily living and quality of life in these patients and to correlate the impact with severity of disease in the set up of Indian conditions using Seattle obstructive lung disease Questionnaire. The study has been approved by the Research committee and Ethical committee of the Institute. This questionnaire evaluates longitudinal differences within persons over time and also discriminative purpose, such as differentiating between groups of patients with varying disease severity. The physical function scale assesses the degree of dyspnea and the extent of physical limitation. The emotional function scale measures the impact of the disease on patient's psychological well-being. The coping skills scale measures self-effi cacy which refl ects a patient's conviction regarding his/her ability to achieve a certain outcome and is an important determinant of successful behavior change.
The fourth dimension, treatment satisfaction, measures how satisfi ed patients are with the therapy they are getting for COPD. The higher the score on each dimension of the questionnaire, the better is the health related quality of life in patients.
MATERIALS AND METHODS
A prospective study was designed to verify whether the impact of activities of daily living and quality of life in patients suffering from Chronic obstructive pulmonary disease correlates with the severity of disease. The study was approved by research and ethical committee of Institute. Seventy eight stable COPD patients with no history of exacerbation in past 4 weeks attending the chest clinic of institute were enrolled. Patients with co-morbidities were excluded so that effect of COPD on quality of life could be studied without contribution of other co-morbid conditions like past history of tuberculosis, hypertension, diabetes, liver disease, renal disease and other neurological and muscular disabilities. Twenty healthy individuals were enrolled as controls. Informed written consent was obtained from all the participants. A detail clinical history and physical examination, routine blood tests, chest X-ray, and spirometry were performed for each participant. All the participants fi lled the Seattle obstructive lung disease questionnaire translated in local language and performed six-minute walk distance test as per American Thoracic Society guidelines. [3] Seattle obstructive lung disease questionnaire translated in Hindi language was earlier validated in our department to study the impact of pulmonary rehabilitation on morbidity due to chronic obstructive lung disease in 30 patients. The Hindi version of the SOLDQ was developed following the forward-backward translation procedure with independent translations and counter-translations. The dyspnea level of participants was also assessed by Visual analog scale. [4] The staging of severity of COPD was done according to GOLD 2006 guidelines [5] as mild, moderate or severe or very severe disease based on the spirometric evaluation.
RESULTS
Seventy eight stable COPD patients with mean age of 52.5 ± 10.18 years were enrolled. There were 19 (24.4%) female patients with mean age of 48.4 years. The mean age of male patients was 53.8 years. The mean age of controls was 51.30 ± 9.87) years. The disease severity was classifi ed as per GOLD 2006 guidelines. Twenty two patients had mild and 21 had moderate disease. There were 23 patients with severe and 12 with very severe COPD. The patient characteristics of each study group are shown in Table 1 .
Bidi smoking was found to be the most prevalent form of smoking in our patient group. The smoking preferences and smoke exposures of patients have been shown in Table 2 .
The physical function score, emotional function score, coping skills scores, treatment satisfaction scores, six minutes walk distance and Visual analog scale scores is shown in Table 3 . Analysis of the data was done with Microsoft Excel XP (Microsoft, Seattle WA) and SPSS version 13.0 software (SPSS inc., Chicago, IL). The collected data has been expressed as mean ± SD or median with inter-quartile range (1st quartile-third quartile) depending on the distribution of data. Each parameter was tested for normality in the distribution of data using standard normality tests (D' Agostino-Pearson omnibus normality test and Shapiro-Wilk test), and subsequently appropriate parametric or non-parametric tests were applied. The variables in the various groups of patients were compared using one way analysis of variance (ANOVA) test and post hoc analysis between the groups. The relationship between two parameters was evaluated using Pearson's correlation coeffi cient or Spearman's rank correlation coeffi cient as appropriate. A value of P < 0.05 was considered statistically signifi cant. The physical function score and emotional function score, decreased signifi cantly (P < 0.05) when compared from mild through moderate, severe and very severe stages of COPD [ Table 3 ]. The physical function score for mild through moderate, severe and very severe stages of COPD was 85.57 ± 5.48, 72.85 ± 10.52, 56.91 ± 9.84, and 44.18 ± 13.49 respectively. The emotional function score for mild through moderate, severe and very severe stages of COPD was 96.65 ± 5.48, 84.6 ± 13.1, 76.08 ± 12.37, and 57.22 ± 19.63 respectively. Coping skills scores were also decreased signifi cantly (P < 0.05) when compared from mild through moderate, severe and very severe stages of COPD. The treatment satisfaction scores did not differ signifi cantly with change in severity of the disease (P value > 0.05). The treatment satisfaction score could not be compared with control group because the controls were healthy subjects and not on any treatment. The health related quality of life dimensions scores in relation to COPD severity according to GOLD guidelines are shown in [ Figure 1 ]. The Forced expiratory volume in fi rst second (FEV 1 ) actual as well as percent predicted FEV 1 correlated positively with the physical function score (r = 0.827, P = 0.000 and r = 0.855, P = 0.000 respectively) and emotional function score (r = 0.725, P = 0.000 and r = 0.735, P = 0.000 respectively) as shown in [ Figures 2 and 3 ]. The six minutes walk distance decreases with the severity of disease. It was 492 ± 63.6, 464.6 ± 76.7, 394.2 ± 69, and 331.1 ± 80.6 meters for mild, moderate, severe, and very severe COPD patients respectively. In control group 6MWD was 530 ± 53 meters. The fall in 6MWD was statistically signifi cant as the disease progress in severity from moderate to severe and very severe as per the GOLD 2006 guidelines. There was no statistically signifi cant difference in 6MWD as the disease increases in severity from mild and moderate COPD (P value = 0.192). The physical function score of SOLDQ which measures the physical activity level of COPD patients correlated positively with 6MWD (r = 0.709, P = 0.000), after controlling for confounding variables including height, weight, Body mass index, hemoglobin level and age [ Figure 4 ] The Visual analog scale score for dysponea signifi cantly increases (P < 0.05) as the disease progress from mild through moderate, severe, and very severe COPD [ Table 1 ]. The VAS correlated negatively with physical functions scores (r = −0.827, P = 0.000) and emotional function score of SOLDQ signifi cantly (r = −0.744, P = 0.00).
DISCUSSION
COPD is a disease of adults occurring usually after 40 years of age. Its occurrence depends upon many factors and Tobacco smoking is the most important risk factor. In our study, mean age of 78 enrolled COPD patients was 52.5 years and about two third of patients (n = 59) were in the productive age group and less than 60 years of age. The eldest patient in our study was 70 years old and six patients were below 40 years of age. Women are more susceptible to the disease and develop COPD at an earlier age than the men, despite of lesser duration of exposure to smoke. [6] However, in our study there were only 25 % (n = 19) female patients.. Other studies have also observed this age related gender difference. [7, 8] Often the women and their family members neglect the symptoms of disease occurring in women [9] and less number of women are able to utilize health care facilities due to various social factors. [10] Morbidities due to COPD affect all aspects of life, including work and home life, physical and sexual aspects of marriage, internal emotional factors and dependence needs. [11] GOLD guidelines are widely used to categorize COPD patients into various stages on the basis of percent predicted FEV 1 and FEV 1 /FVC ratio. In this study disease severity was determined as per GOLD 2006 guidelines. [5] The associated loss of physical capacity and the adverse psychological effects of the disorder contribute greatly to the activities of daily living (ADL) and health related quality of life of the patients. Activities of daily living are the activities which are performed at suboptimal level of maximum exercise capacity of the individual. Association between health related quality of life (HRQoL) and disease severity based on FEV 1 had been seen [12, 13] with various disease specifi c questionnaires like chronic respiratory disease questionnaire (CRQ), St. George respiratory questionnaire (SGRQ). Seattle obstructive lung disease questionnaire (SOLDQ) has been specifi cally designed and studied to know the effect of COPD on quality of life. The physical function dimension score of the SOLDQ measures the impact on quality of life due to the limitations of physical activities, performed in day to day activities. The more the score of this dimension of questionnaire, the better is the ability of individual with COPD to perform activities of daily living. As the disease progressed in severity, the physical function scores decreased signifi cantly. In our study patients with COPD in all stages of disease have signifi cantly reduced physical functioning scores. The mean physical functioning score of SOLDQ ranged from 85.5 in stage I (mild COPD) to 44 in GOLD stage IV (very severe COPD) disease. Similarly, Elisabeth S et al, had also observed statistically signifi cant difference in SGRQ score in all stages of COPD. [14] Antonelli Inclazi R et al, [15] observed signifi cant differences in SGRQ scores between stages III and IV of disease, whereas changes from stage 0 to stage II were not signifi cant. They had classifi ed their patient as per GOLD 2001 guidelines. The emotional function or psychological effects of the disease and the coping skills are other determinants of quality of life. [16] [17] [18] In our patients emotional function score, decreased signifi cantly (P < 0.05) when compared from mild through moderate, severe and very severe stages of COPD. The deterioration in coping skills score was not found statistically different in patients with severe to very severe stage of disease (P = 0.095) as these skills in these patients were probably jeopardized due to more severe symptoms and more limitation in activities of daily living. The treatment satisfaction scores did not differ signifi cantly with change in severity of the disease. This implies that patients were not fully satisfi ed by the treatment, they were receiving. The reason for which might be that many of them were from poor socioeconomic backgrounds and could not afford all the medicines and treatment options available, which could have improved their symptoms further. Also, the patients with severe disease have more symptoms, so treatment they receive might not eliminate all of their symptoms completely, in spite of optimal treatment, resulting in poor quality of life scores and reduced scores of treatment satisfaction dimension. 6-MWD can be an indicator of ability of physical activity of the patient. As the disease severity progresses the 6 minute walk distance in COPD patients gradually decreases with decrease in FEV 1 . [19] In our study there was statistically signifi cant decrease in 6-MWD from moderate to severe and very severe COPD patients classifi ed as per the GOLD guidelines. The positive correlation between the physical function score and 6-MWD suggests that the physical activities are reduced with increasing severity of COPD. Another uni-dimensional scale like Visual analog scale may be combined with a multidimensional scale (like SOLDQ) for measuring disease specifi c quality of life. VAS measure subjective feeling of breathlessness in COPD patients. [20] In our study, we found that VAS scores means were lower in patients with COPD as compared to healthy controls in all stages of COPD. The recent GOLD guidelines has also emphasized on the use of quality of life scores and grading of breathlessness in the form of MMRC grade for classifi cation of disease staging and the management is based on this classifi cation. [21] The study has limitations because of small number of patients in all four groups and it is suggested to confi rm these results in a study with large number of patients in each group. Secondly, patients with exacerbations of COPD were excluded. Patient with each exacerbation has more deterioration in quality of life and these patients were excluded in our study and therefore, the effect of exacerbations on the activities of daily living has not been studied in this study. COPD has impact on activities of daily living and health related quality of life. Spirometry is used to confi rm the diagnosis of COPD, but the spirometry parameters alone may not be able to classify diseases severity, and the quality of life scores are also required to assess the disease severity. Therefore, these scores may be helpful in providing physicians with the ability to monitor the quality of life and activities of daily living, thereby suggesting change in the health status of the patient which may be caused by change in COPD severity. Suffering from Chronic obstructive pulmonary disease correlates with the severity of disease. 
